Boehringer Ingelheim - Recruiting 18 years or older. - A 24-week Phase III Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Twice Daily Oral Administration of Empagliflozin + Metformin Compared With the Individual Components of Empagliflozin or Metformin in Drug Naive Patients With Type 2 Diabetes Mellitus.
Heinrich-Heine University, Duesseldorf - Recruiting 18 years or older. - Observational Study on the Prognostic Relevance of Admission Glycated Hemoglobin (HbA1C) in Patients With Aneurysmal Subarachnoid Hemorrhage.
Katholieke Universiteit Leuven - Recruiting 18 years or older. - LOGIC-Insulin Computerized Algorithm-guided Versus Nurse-directed Blood Glucose Control in Critically Ill Patients: the LOGIC-2 Multicentre Randomized Controlled Trial.
Northwestern University - Recruiting 18 years to 80 years. - Prospective, Randomized, Open-Label, Controlled Study to Evaluate the Safety and Efficacy of Intensive Glycemic Control on Outcomes Following Liver Transplantation.
Eli Lilly and Company - Recruiting 20 years or older. - A Phase 3, Open Label, Randomized, Parallel, 26 Week Treatment Study Comparing LY2605541 With Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti Hyperglycemia Medications in Asian Insulin Nave Patients With Type 2 Diabetes Mellitus.
Emory University - Recruiting 18 years to 80 years. - Prospective Study Aim to Determine the Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Cardiac Surgery Patients With Perioperative Hyperglycemia.
Taipei Veterans General Hospital, Taiwan - Recruiting 30 years to 80 years. - á-Cell Function and Glycemic Control of Basal Insulin, Metformin or Sitagliptin in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia.
Poissy-Saint Germain Hospital - Recruiting 18 years or older. - Multicentre Randomized Trial Assessing the Impact of Maintaining 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted to the ICU (INSUREA STUDY).
Strict glycemic control; Conventional glycemic control